Cognitive Behavioral Therapy for Adolescent Depression
(PATHway Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different therapies can prevent depressive disorders in adolescents. It focuses on the CATCH-IT program (Competent Adulthood Transition with Cognitive-Behavioral, Humanistic, and Interpersonal Training), which includes modules like cognitive-behavioral, humanistic, and interpersonal therapy. Researchers will divide participants into groups to determine which therapy combinations are most effective. Teens aged 13 to 18 with past depressive symptoms but not currently experiencing a depressive episode might be suitable candidates. As an unphased trial, this study offers participants a unique chance to contribute to innovative research that could shape future mental health interventions for adolescents.
Do I have to stop taking my current medications to join the trial?
Yes, you must stop taking any current medication therapy for depression, anxiety, or other internalizing disorders to participate in this trial.
Will I have to stop taking my current medications?
Yes, you will need to stop taking any current medication therapy for depression, anxiety, or other internalizing disorders to participate in this trial.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the treatment being tested, called CATCH-IT, is safe and well-tolerated based on previous studies. This program aims to help prevent depression in teens by using various therapy methods. These include cognitive-behavioral therapy, which helps change negative thinking; humanistic therapy, which focuses on personal growth; and interpersonal therapy, which improves relationships.
In these studies, CATCH-IT proved safe for teenagers at risk of depression. The treatment was also described as practical, meaning it can be easily used with teens. Importantly, there were no major reports of negative side effects linked to CATCH-IT, suggesting it is a safe option for adolescents.
This information can reassure those considering joining the trial, as the treatment has been tested before without major safety concerns.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for adolescent depression because they combine multiple therapy approaches, aiming to address the condition more comprehensively than traditional methods. Unlike standard treatments that often focus solely on cognitive-behavioral therapy (CBT), these new treatments integrate interpersonal therapy and behavioral activation alongside CBT. This multi-faceted approach targets different aspects of depression, potentially leading to more effective and long-lasting results. Additionally, the inclusion of parent modules in some treatments is unique, as it seeks to create a supportive environment by involving family members in the therapeutic process, which could enhance the overall impact on adolescents’ mental health.
What evidence suggests that this trial's treatments could be effective for adolescent depression?
Research shows that the CATCH-IT program can help reduce depression symptoms in teenagers. In this trial, participants will join various treatment arms, including different combinations of adolescent and parent program modules. One study found that CATCH-IT effectively lowered these symptoms over time compared to other methods. Another study showed that teens who participated in CATCH-IT experienced better moods and improved coping skills. These results suggest that CATCH-IT's structured lessons, which include activities to change behavior, improve thinking patterns, and enhance relationships, can help manage and prevent depression in young people. The program also involves parents, creating a supportive environment that can enhance its effectiveness for teens.14678
Who Is on the Research Team?
Benjamin W Van Voorhees, MD, MPH
Principal Investigator
UIC, College of Medicine
Calvin Rusiewski, MBBS
Principal Investigator
UIC, College of Medicine
Tracy RG Gladstone, PhD
Principal Investigator
Wellesley College
Are You a Good Fit for This Trial?
This trial is for adolescents aged 13-18 with mild to moderate depression symptoms (PHQ-9 score of 5-18), who may have had past depressive episodes but are not currently in one. Participants must speak English, be willing to follow the study protocol, and not be on medication or in therapy for mood disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the CATCH-IT program, which includes various modules such as behavioral activation, cognitive-behavioral therapy, and interpersonal psychotherapy, tailored to optimize intervention efficacy, tolerability, and scalability.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of various psychological and behavioral outcomes.
Implementation Preparation
Preparation for implementation studies and dissemination, focusing on optimizing intervention components for scalability and acceptability.
What Are the Treatments Tested in This Trial?
Interventions
- Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training is already approved in United States for the following indications:
- Depression prevention in adolescents
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
Wake Forest University Health Sciences
Collaborator
Endeavor Health
Collaborator
Mile Square Health Center
Collaborator
Lawndale Christian Health Center
Collaborator
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
National Institute of Mental Health (NIMH)
Collaborator
NorthShore University HealthSystem
Collaborator
Advocate Health Care
Collaborator
Wellesley College
Collaborator